News - Baxter International

Filter

Current filters:

Baxter International

Popular Filters

1 to 25 of 27 results

Baxter to acquire Chatham Therapeutics for $70 million

03-04-2014

USA-based Baxter International says it has agreed to acquire Chatham Therapeutics, a private biotechnology…

Baxter InternationalBiotechnologyChatham TherapeuticsHematologyMergers & Acquisitions

Baxter to split, creating two separate health care companies

Baxter to split, creating two separate health care companies

28-03-2014

News that USA-based Baxter International plans to create two separate, independent global health care…

Baxter InternationalManagementMergers & AcquisitionsPharmaceutical

Onconova tanks, as lead drug rigosertib fails in Ph III MDS study

Onconova tanks, as lead drug rigosertib fails in Ph III MDS study

21-02-2014

US biotech firm Onconova Therapeutics saw its shares plunge 37% to $8.70 in pre-market trading yesterday…

Baxter InternationalOncologyOnconova TherapeuticsPharmaceuticalResearchrigosertib

Baxter restructures deal with Xenetic Biosciences

31-01-2014

USA-based Baxter International has restructured its ongoing agreement with Xenetic Biosciences for the…

BAX 826Baxter InternationalHematologyLicensingPharmaceuticalResearchXenetic Biosciences

Baxter’s Feiba gains FDA approval for prophylactic treatment of hemophilia A and B

Baxter’s Feiba gains FDA approval for prophylactic treatment of hemophilia A and B

20-12-2013

US drugmaker Baxter International has received approval from the US Food and Drug Administration for…

Baxter InternationalFeibaHematologyPharmaceuticalRegulation

Baxter files amended BLA to FDA for HyQvia for primary immunodeficiency

Baxter files amended BLA to FDA for HyQvia for primary immunodeficiency

02-12-2013

USA-based Baxter International has completed submission of an amended biologics license application to…

Baxter InternationalHalozyme TherapeuticsHyQviaImmunologicalsNorth AmericaPharmaceuticalRegulationUSA

Baxter buys exclusive rights to CTI’s cancer drug pacritinib

18-11-2013

USA-based companies Baxter International and Cell Therapeutics have entered into an exclusive worldwide…

Baxter InternationalCell TherapeuticsFinancialGlobalLicensingOncologypacritinibPharmaceutical

Acquisition costs take toll on Baxter’s 3rd-qtr financials

18-10-2013

USA-based Baxter International has posted solid financial results for the third quarter of 2013, showing…

Baxter InternationalFinancialHematologyPharmaceutical

Vivaldi Biosciences acquires clinical stage influenza vaccine assets

13-10-2013

Privately-held US biotech firm Vivaldi Biosciences has acquired from Baxter Healthcare R&D assets, including…

Anti-viralsBaxter HealthcareBaxter InternationalBiotechnologyMergers & AcquisitionsVaccinesVivaldi Biosciences

Baxter and Coherus in up to $246 million deal for biosimilar etanercept

04-09-2013

US companies Baxter International (NYSE:BAX) and Coherus Biosciences have entered into an exclusive collaboration…

AmgenAnti-Arthritics/RheumaticsBaxter InternationalBiotechnologyCoherus BioSciencesEnbreletanerceptGenericsLicensingResearch

EU Commission puts conditions on Baxter's acquisition of Gambro

23-07-2013

The European Commission has authorized the proposed $4 billion acquisition of privately-held Swedish…

Baxter InternationalGambroMergers & AcquisitionsPharmaceutical

FDA backs Baxter's Rixubis for hemophilia B; Breakthrough status for GSK's drisapersen

28-06-2013

The US Food and Drug Administration yesterday (June 27) approved Baxter International's (NYSE: BAX) Rixubis…

Baxter InternationaldrisapersenGlaxoSmithKlineNorth AmericaPharmaceuticalRare diseasesRegulationRixubis

Baxter shares dip as Alzheimer's drug fails to meet Ph III endpoints

08-05-2013

Shares of US drugmaker Baxter International (NYSE: BAX) fell 2.5% to $68.58 in New York trading on May…

Baxter InternationalGammagardNeurologicalPharmaceuticalResearch

Ipsen and Inspiration Biopharma in deal with Baxter for OBI-1

24-01-2013

French drugmaker Ipsen (Euronext: IPN) and privately-held US firm Inspiration Biopharmaceuticals have…

Baxter InternationalIB1001Inspiration BiopharmaceuticalsIpsenMergers & AcquisitionsOBI-1Pharmaceutical

Baxter to expand renal therapies range with $4 billion buy of Gambro

04-12-2012

Confirming recent rumors and speculation, Baxter International (NYSE:BAX ) said yesterday it has entered…

Baxter InternationalGambroMergers & AcquisitionsNephrology and HepatologyPharmaceutical

Baxter in up to $565 million deal with Onconova for rigosertib

20-09-2012

US companies Baxter International (NYSE: BAX) and privately-held biotech Onconova Therapeutics have entered…

Baxter InternationalEstybonEuropeLicensingOncologyOnconova TherapeuticsPharmaceuticalrigosertib

News briefs: setbacks for B-MS hep C drug; Baxter's HyQ

02-08-2012

US drug major Bristol-Myers Squibb (NYSE: BMY) has suspended study drug administration in ongoing Phase…

Anti-viralsBaxter InternationalBMS-986094Bristol-Myers SquibbHyQImmunologicalsNorth AmericaPharmaceuticalRegulationResearch

Baxter's Gammagard shows potential in stabilizing Alzheimer's

18-07-2012

The first report of long-term (three-year) stabilization of Alzheimer's disease symptoms with intravenous…

Baxter InternationalGammagardNeurologicalPharmaceuticalResearch

Baxter to invest over $1 billion on new facility; post 1st-qtr results

22-04-2012

USA-based Baxter International (NYSE:BAX) has announced plans to build a new state-of-the-art manufacturing…

Baxter InternationalFinancialPharmaceutical

Halozyme plunges as FDA call for more data on HyQ BLA

17-04-2012

USA-based Halozyme Therapeutics saw its shares plummet 24% to $8.56 by close of trading yesterday, after…

Baxter InternationalBiotechnologyHalozyme TherapeuticsHyQImmunologicalsNorth AmericaRegulation

EU Commission OKs Baxter Avian flu vaccine Vepacel; drops GSK probe

05-03-2012

US drugmaker Baxter International (NYSE:BAX) says that the European Commission has granted marketing…

Anti-viralsBaxter InternationalEuropeGlaxoSmithKlineLegalPharmaceuticalRegulationSynthonVaccinesVepacel

Baxter taps Momenta expertise on biosimilars

28-12-2011

In another move to capitalize on the anticipated flood of biosimilars coming to the market, as blockbuster…

Baxter InternationalBiotechnologyGenericsLicensingMomenta PharmaceuticalsResearch

Baxter to acquire Synovis

14-12-2011

The USA’s Baxter International (NYSE: BAX) said yesterday that it has reached agreement to acquire…

Baxter InternationalMergers & AcquisitionsPharmaceuticalSynovis Life Technologies

1 to 25 of 27 results

Back to top